UBV
United Bank (Virginia) Portfolio holdings
AUM $835M
1-Year Return
14.61%
This Quarter Return
+7.58%
1 Year Return
+14.61%
3 Year Return
+55.61%
5 Year Return
+104.58%
10 Year Return
+207.91%
AUM
$82.8M
AUM Growth
+$9.79M
(+13%)
Cap. Flow
+$5.25M
Cap. Flow
% of AUM
6.34%
Top 10 Holdings %
Top 10 Hldgs %
45.8%
Holding
52
New
7
Increased
10
Reduced
21
Closed
1
Top Buys
| 1 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$2.64M |
| 2 |
AGN
Allergan plc
AGN
|
+$1.13M |
| 3 |
Ford
F
|
+$725K |
| 4 |
Vanguard Growth ETF
VUG
|
+$718K |
| 5 |
WisdomTree Europe Hedged Equity Fund
HEDJ
|
+$688K |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$521K |
| 2 |
Merck
MRK
|
+$380K |
| 3 |
Amgen
AMGN
|
+$280K |
| 4 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$261K |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$260K |
Sector Composition
| 1 | Healthcare | 20.06% |
| 2 | Technology | 16.14% |
| 3 | Consumer Discretionary | 6.97% |
| 4 | Consumer Staples | 6.75% |
| 5 | Energy | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Intel
INTC
$116B
| $1.51M | 1.83% |
43,928
| – | – |
|
|
27
Qualcomm
QCOM
$174B
| $1.28M | 1.54% |
25,553
-10,433
| -29% | -$521K |
|
28
HF Sinclair
DINO
$9.66B
| $1.09M | 1.32% |
27,435
+232
| +0.9% | +$9.25K |
|
29
Procter & Gamble
PG
$367B
| $996K | 1.2% |
12,553
-700
| -5% | -$55.5K |
|
30
Norfolk Southern
NSC
$62.2B
| $699K | 0.84% |
8,267
| – | – |
|
31
Exxon Mobil
XOM
$479B
| $619K | 0.75% |
7,944
-400
| -5% | -$31.2K |
|
32
International Paper
IP
$24.1B
| $579K | 0.7% |
16,230
| – | – |
|
33
Gilead Sciences
GILD
$140B
| $566K | 0.68% |
5,594
| – | – |
|
34
Rockwell Automation
ROK
$39B
| $498K | 0.6% |
4,854
| – | – |
|
35
Bristol-Myers Squibb
BMY
$94.3B
| $469K | 0.57% |
6,812
| – | – |
|
36
Consumer Discretionary Select Sector SPDR Fund
XLY
$24.3B
| $443K | 0.53% |
+5,662
| New | +$443K |
|
37
Coterra Energy
CTRA
$18.5B
| $434K | 0.52% |
24,576
-6,523
| -21% | -$115K |
|
38
Palo Alto Networks
PANW
$135B
| $416K | 0.5% |
14,160
| – | – |
|
39
Biogen
BIIB
$21B
| $392K | 0.47% |
1,279
| – | – |
|
|
CELG
40
DELISTED
Celgene Corp
CELG
| $391K | 0.47% |
3,268
| – | – |
|
|
MNK
41
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $364K | 0.44% |
4,873
| – | – |
|
42
Teva Pharmaceuticals
TEVA
$21.7B
| $349K | 0.42% |
+5,315
| New | +$349K |
|
43
AbbVie
ABBV
$384B
| $294K | 0.35% |
4,958
| – | – |
|
44
Berkshire Hathaway Class B
BRK.B
$1.06T
| $274K | 0.33% |
2,075
-143
| -6% | -$18.9K |
|
|
45
Alphabet (Google) Class A
GOOGL
$3.04T
| $250K | 0.3% |
+6,440
| New | +$250K |
|
|
46
Alphabet (Google) Class C
GOOG
$3.04T
| $243K | 0.29% |
6,420
-6,880
| -52% | -$260K |
|
|
JCAP
47
DELISTED
Jernigan Capital, Inc.
JCAP
| $241K | 0.29% |
16,090
+3,090
| +24% | +$46.3K |
|
48
JPMorgan Chase
JPM
$849B
| $223K | 0.27% |
+3,373
| New | +$223K |
|
49
GE Aerospace
GE
$304B
| $219K | 0.26% |
+1,469
| New | +$219K |
|
|
SHPG
50
DELISTED
Shire pic
SHPG
| $219K | 0.26% |
1,066
-890
| -46% | -$183K |
|